Stockholders’ Equity (Details) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2021	Mar. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Dec. 31, 2021
Stockholders’ Equity (Details) [Line Items]
Restricted shares value			$ 0
Recognized stock based compensation expense			$ 1,004,385
Series A convertible preferred stock, issued (in Shares)			13,602		13,602
Accrued dividends			$ 306,045
Series A convertible preferred stock, liquidation preference (in Dollars per share)			$ 25
Series A convertible preferred stock, dividend rate			6.50%
Weighted average of the last sales prices			95.00%
Dividend rate increase			10.00%
Preferred stock conversion price per share (in Dollars per share)			$ 12
Stockholders equity, description			If the closing sale price of the common stock is greater than 140% of the conversion price on 20 out of 30 trading days, the company may redeem the Series A Preferred Stock in whole or in part at any time through October 31, 2010, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the shares to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, subject to certain conditions. In addition, beginning November 1, 2010, the company may redeem the Series A Preferred Stock in whole or in part, upon at least 30 days’ notice, at a redemption price, payable in cash, equal to 100% of the liquidation preference of the Series A Preferred Stock to be redeemed, plus unpaid dividends thereon to, but excluding, the redemption date, under certain conditions.
Common stock discount shares description			The purchase price is payable, at the corporation’s option, (x) in cash, (y) in shares of the common stock at a discount of 5% from the fair market value of Common Stock on the Purchase Date (i.e. valued at a 95% discount of the Common Stock on the Purchase Date), or (z) any combination thereof.
Preferred stock, annual dividend			$ 34,000	$ 34,000
Reserved a total possible issuance under the plan (in Shares)			50,000,000
Total stock-based compensation expense for grants			$ 1,004,385	493,367
Share based compensation of restricted stock agreement shares (in Shares)					140,000
Restricted stock awards value				84,000
Recognized restricted stock awards value				$ 70,000
Restricted stock, grants description			The shares vest annually over two years with the first installment one year from the agreement; provided, however, if either party terminates the agreement at any time prior to the last date of it ending, then the shares will vest, pro rata, for each month served since the most recent prior annual vesting date.
Stock based compensation description			The $1,004,385 stock-based compensation for the six months ended June 30, 2022, was comprised of $781,385 option expense and $223,000 was the amortization of 5,000,000 shares of stock valued at $0.4014 over three years for the acquisition of assets of Applied Optical Sciences.
Unrecognized stock based compensation			$ 3,880,836
Stock based compensation restricted stock agreements			$ 0		$ 15,355
Common Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares (in Shares)		7,056,250	158,329
Shares issued for convertible notes (in Shares)			47,999
Restricted Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares (in Shares)			31,250
Stock value issued for restricted stock agreement			$ 4,550
Warrant [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares (in Shares)			600,000
Stock value issued for exercise of warrants (in Shares)			600,000
Warrant exercise price per share (in Dollars per share)			$ 0.07
Options [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares (in Shares)				1,005,682
Common stock option exercise (in Shares)	1,090,910			1,090,910
Stock option exercise price Per share (in Dollars per share)				$ 0.05
Restricted Stock Agreement [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares (in Shares)			130,417
Options Two [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares (in Shares)			100,000
Net cash proceeds			$ 13,000
Common stock option exercise (in Shares)			100,000
Stock option exercise price Per share (in Dollars per share)			$ 0.13
Preferred Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares (in Shares)
Liquidation preference			101.00%
Minimum [Member]
Stockholders’ Equity (Details) [Line Items]
Liquidation preference			1.00%
Maximum [Member]
Stockholders’ Equity (Details) [Line Items]
Liquidation preference			6.50%
Private Placement [Member]
Stockholders’ Equity (Details) [Line Items]
Common stock shares (in Shares)	7,056,250
Price per share (in Dollars per share)	$ 0.32
Net cash proceeds	$ 2,258,000
Series A Preferred Stock [Member]
Stockholders’ Equity (Details) [Line Items]
Series A convertible preferred stock, issued (in Shares)			13,602		13,602
Liquidation preference			7.50%
Business Combination [Member]
Stockholders’ Equity (Details) [Line Items]
Issuable in acquisition, description			As of June 30, 2022 and December 31, 2021, the company in aggregate recorded $1,561,000 and $1,338,000, respectively, in stock-based compensation related to a lockup agreement on 5,000,000 shares of common stock in the acquisition of assets of AOS valued at $0.4014 per share, representing the closing price on the date of the contract which is amortized over 36 months, of which, $223,000 and $334,000, respectively, was amortized for the six months ended June 30, 2022, and 2021.
Statements of operations [Member]
Stockholders’ Equity (Details) [Line Items]
Preferred stock, annual dividend			$ 17,003	$ 17,003